European Pathology Laboratories and COVID-19

CompletedOBSERVATIONAL
Enrollment

71

Participants

Timeline

Start Date

March 15, 2020

Primary Completion Date

May 31, 2020

Study Completion Date

May 31, 2020

Conditions
Clinical Practice During the COVID-19 Crisis
Interventions
OTHER

Activity

The questionnaire had requested information on the biosafety organization, impact of the COVID-19 crisis on the clinical and molecular pathology and the biobanking activity in thoracic pathology, on the research activity associated with the COVID-19, and on the educational and training organization. It requested the different needs planned by the different laboratories following the COVID-19 crisis and finally the consequence of this latter on the health and virological status of the staff members.

Trial Locations (1)

06001

CHU de Nice, Nice

All Listed Sponsors
lead

Centre Hospitalier Universitaire de Nice

OTHER

NCT04476823 - European Pathology Laboratories and COVID-19 | Biotech Hunter | Biotech Hunter